Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

KENDALL E HANSEN MD PLC

NPI: 1174528392 · CRESTVIEW HILLS, KY 41017 · Nurse Practitioner · NPI assigned 06/15/2005

$450K
Total Medicaid Paid
39,220
Total Claims
29,187
Beneficiaries
23
Codes Billed
2018-01
First Month
2022-04
Last Month

Provider Details

Authorized OfficialHANSEN, KENDALL (M.D., PRESIDENT & CEO)
NPI Enumeration Date06/15/2005

Related Entities

Other providers sharing the same authorized official: HANSEN, KENDALL

ProviderCityStateTotal Paid
CRESTVIEW HILLS SURGERY CENTER, PLLC CRESTVIEW HILLS KY $66K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 13,582 $183K
2019 9,547 $106K
2020 9,134 $85K
2021 6,890 $73K
2022 67 $2K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 2,511 2,153 $150K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,869 8,534 $148K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,083 2,712 $63K
99152 4,918 3,484 $18K
27096 304 214 $16K
64635 198 143 $13K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,563 1,033 $9K
64636 138 91 $5K
99441 650 496 $5K
99442 308 224 $5K
64483 134 97 $5K
64493 128 82 $4K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 68 55 $2K
64494 80 55 $2K
J3490 Unclassified drugs 4,954 3,451 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 4,691 3,513 $1K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 486 395 $858.61
J1030 Injection, methylprednisolone acetate, 40 mg 731 575 $837.89
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,228 1,732 $331.15
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 37 29 $249.47
J0690 Injection, cefazolin sodium, 500 mg 15 12 $2.52
J2405 Injection, ondansetron hydrochloride, per 1 mg 111 94 $2.34
J2250 Injection, midazolam hydrochloride, per 1 mg 15 13 $0.33